[SCENARIO] id=74 | sector=entertainment | agents=3 | rounds=20
[AGENTS] 1=Theatrical & Windowing Strategy Director, 2=Marketing Analytics & Media Planning Lead, 3=Legal & Business Affairs Counsel
[GOAL] Produce a final recommendation on whether to keep a planned wide theatrical release for a mid-budget studio thriller or pivot to a hybrid theatrical-to-PVOD window, aligning distribution economics, marketing effectiveness, and contractual/legal constraints while minimizing reputational and partner risk.

[R0.1] Theatrical & Windowing Strategy Director (speak, public): Let's discuss the release strategy for our mid-budget studio thriller. We have a current plan for a wide theatrical release on Oct 9, 2026, with an exclusive window of 45 days. I'd like to get your thoughts on demand and awareness, as well as any constraints that might impact our decision.
[R0.2] Marketing Analytics & Media Planning Lead (speak, public): We have some early indicators on teaser/trailer performance and audience awareness. Our teaser completion rate is 41% and click-through rate is 1.3% across platforms. Additionally, unaided awareness among our target demographic of 18-34-year-olds is currently at 16%, which is below our target benchmark of 22%. I'd like to understand the planned release timing and window shape better to calibrate our marketing spend effectively. Are there any updates or considerations on the release schedule that we should be aware of?
[R0.3] Legal & Business Affairs Counsel (speak, public): The planned release date is October 9, 2026, with a 45-day exclusive theatrical window. We've got an exhibitor window covenant that requires maintaining at least a 31-day exclusive theatrical window for 5 major chains. Additionally, we're on track with our ratings and clearance milestone, with the MPA submission due on August 25, 2026, and we have one discretionary cut planned.

[R1.1] Theatrical & Windowing Strategy Director (speak, public): Our current plan is to release the film wide on October 9, 2026, with a 45-day exclusive window. We've seen some early demand indicators that show T-30 presales at 62,000 tickets, which is below the comp-set median of 95,000 tickets. We're also projecting an opening-weekend availability of 3,050 screens with 2 competing wide openers. I'd like to discuss whether these indicators suggest we should stick with our current plan or consider an alternate window scenario.
[R1.2] Marketing Analytics & Media Planning Lead (speak, public): To better calibrate our marketing spend and understand the release strategy, I'd like to clarify if there are any non-obvious distribution economics or potential pivots we're considering given the current demand indicators. Additionally, are there any specific approval milestones that could affect our creative assets or messaging?
[R1.3] Legal & Business Affairs Counsel (speak, public): To address the current demand indicators and potential pivots, we should consider our contractual constraints and any internal trigger thresholds that might impact our decision. We've got a clear exhibitor window covenant and ratings/clearance milestone on track. I'd like to understand if there are any undisclosed commercial commitments or internal triggers that could affect our release strategy.

[R2.1] Theatrical & Windowing Strategy Director (speak, public): We've considered an alternate window scenario where the film releases theatrically on October 9, 2026, and becomes available on PVOD on day 18. This could potentially impact our marketing strategy and distribution economics. I'd like to discuss the implications of this scenario further, especially regarding any contractual constraints or internal triggers that might be affected.
[R2.2] Marketing Analytics & Media Planning Lead (speak, public): To assess the implications of the alternate window scenario on our marketing strategy, I'd like to share some insights. Our current paid media budget is $14.0M, with 60% allocated to digital video. We've seeded 35 influencers as part of our creator activation plan, with an embargo lift date of Sep 20, 2026. However, we need to consider how a shortened theatrical window might impact our marketing effectiveness and whether it aligns with our contractual obligations. Can we discuss the potential impact on our distribution economics and any contractual constraints we should be aware of?
[R2.3] Legal & Business Affairs Counsel (speak, private to=Theatrical & Windowing Strategy Director): To assess the implications of the alternate window scenario, we need to consider both contractual constraints and potential internal triggers. We've got a clear exhibitor window covenant that requires at least a 31-day exclusive theatrical window for 5 major chains. I'd like to understand if there are any undisclosed commercial commitments or internal triggers that could be affected by shortening the window to 18 days.

[R3.1] Theatrical & Windowing Strategy Director (speak, private to=Legal & Business Affairs Counsel): The alternate window scenario we're considering involves releasing the film theatrically on October 9, 2026, and making it available on PVOD on day 18. We need to assess the contractual implications and potential internal triggers that might be affected by this change. Our current plan has a 45-day exclusive window, and we've got commitments with exhibitors that require at least a 31-day window for 5 major chains. I'd like to understand if shortening the window to 18 days triggers any contractual penalties or internal thresholds.
[R3.2] Marketing Analytics & Media Planning Lead (speak, public): To better understand the implications of the alternate window scenario on our distribution economics, I'd like to ask: How do we expect the shortened theatrical window to affect our revenue projections and exhibitor relationships? Additionally, are there any specific contractual constraints or internal triggers that we need to be aware of in this scenario?
[R3.3] Legal & Business Affairs Counsel (speak, public): To assess the implications of the alternate window scenario on our distribution economics and contractual constraints, I'd like to clarify that we have a merchandising tie-in license with an 8% royalty rate and a minimum guarantee of $650,000. We should also consider our international dubbing and ADR requirements, particularly for Spanish ADR, which has a union minimum of $9,500 for a 22-minute session. Additionally, we need to ensure compliance with our ratings and clearance milestone, with the MPA submission due on August 25, 2026. Let's discuss how these factors might be affected by the proposed changes to our release strategy.

[R4.1] Theatrical & Windowing Strategy Director (speak, public): To address the implications of the alternate window scenario on our distribution economics and contractual constraints, let's summarize the key points. We're considering a theatrical release on October 9, 2026, with PVOD availability on day 18. We've got contractual constraints, including an exhibitor window covenant requiring at least a 31-day exclusive theatrical window for 5 major chains. Additionally, we have a merchandising tie-in license with an 8% royalty rate and a minimum guarantee of $650,000. We need to assess whether shortening the window to 18 days triggers any contractual penalties or internal thresholds. I'd like to discuss these factors further and understand their impact on our release strategy.
[R4.2] Marketing Analytics & Media Planning Lead (speak, public): To assess the implications of the alternate window scenario on our marketing strategy and contractual constraints, I'd like to summarize our current marketing plans and potential risks. Our paid media budget is $14.0M, with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift date of Sep 20, 2026. We need to consider how a shortened theatrical window might impact our marketing effectiveness and whether it aligns with our contractual obligations. Additionally, are there any specific internal triggers or thresholds that we need to be aware of in this scenario?
[R4.3] Legal & Business Affairs Counsel (speak, public): To further assess the implications of the alternate window scenario on our distribution economics and contractual constraints, I'd like to clarify that we need to consider both the exhibitor window covenant and our merchandising tie-in license. We've got a clear requirement to maintain at least a 31-day exclusive theatrical window for 5 major chains, and we're also bound by a merchandising tie-in license with an 8% royalty rate and a minimum guarantee of $650,000. Additionally, we should consider our international dubbing and ADR requirements. Let's discuss how these factors might be affected by the proposed changes to our release strategy.

[R5.1] Theatrical & Windowing Strategy Director (speak, public): To summarize, we're considering two release strategies for our mid-budget studio thriller: the current plan with a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. We've identified key contractual constraints, including an exhibitor window covenant requiring at least a 31-day exclusive window for 5 major chains, and a merchandising tie-in license with an 8% royalty rate. Let's discuss the potential impact of shortening the window on our distribution economics, marketing effectiveness, and contractual obligations.
[R5.2] Marketing Analytics & Media Planning Lead (speak, public): To summarize our discussion on the release strategy for our mid-budget studio thriller, we have two scenarios: a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. Our current paid media budget is $14.0M, with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift date of Sep 20, 2026. We've identified key contractual constraints, including an exhibitor window covenant requiring at least a 31-day exclusive window for 5 major chains, and a merchandising tie-in license with an 8% royalty rate. To finalize our recommendation, I'd like to confirm: Are there any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window, and how might it impact our marketing effectiveness and contractual obligations?
[R5.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation, I'd like to confirm that we need to assess the potential impact of shortening the theatrical window to 18 days on our contractual obligations and internal triggers. We've identified key contractual constraints, including the exhibitor window covenant and merchandising tie-in license. Let's discuss any internal triggers or thresholds that might be affected by this change.

[R6.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation, let's summarize the key points discussed. We're considering two release strategies: a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. We've identified contractual constraints, including an exhibitor window covenant and a merchandising tie-in license. We need to assess the impact of shortening the window on our distribution economics, marketing effectiveness, and contractual obligations. I'd like to confirm if there are any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window.
[R6.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation, I'd like to confirm that we've considered the key factors: our current paid media budget is $14.0M with 60% allocated to digital video, we've seeded 35 influencers with an embargo lift date of Sep 20, 2026, and we've identified contractual constraints including an exhibitor window covenant and a merchandising tie-in license. Are there any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window, and how might it impact our marketing effectiveness and contractual obligations?
[R6.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation, I'd like to confirm that we've considered the key contractual constraints, including the exhibitor window covenant and merchandising tie-in license. We should also be aware of our international dubbing and ADR requirements. Let's discuss any internal triggers or thresholds that might be affected by shortening the theatrical window to 18 days.

[R7.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation, let's summarize the key points discussed. We're considering two release strategies: a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. We've identified contractual constraints, including an exhibitor window covenant and a merchandising tie-in license. We need to assess the impact of shortening the window on our distribution economics, marketing effectiveness, and contractual obligations. I'd like to confirm if there are any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window.
[R7.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation, I'd like to summarize the key points discussed. We've considered two release strategies: a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. Our current paid media budget is $14.0M, with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift date of Sep 20, 2026. We've identified contractual constraints, including an exhibitor window covenant and a merchandising tie-in license. To confirm, are there any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window, and how might it impact our marketing effectiveness and contractual obligations?
[R7.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation, I'd like to confirm that we've considered the key contractual constraints, including the exhibitor window covenant and merchandising tie-in license. We should also be aware of our international dubbing and ADR requirements. Let's discuss any internal triggers or thresholds that might be affected by shortening the theatrical window to 18 days.

[R8.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation, let's summarize the key points discussed. We've considered two release strategies: a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. We've identified contractual constraints, including an exhibitor window covenant and a merchandising tie-in license. We need to assess the impact of shortening the window on our distribution economics, marketing effectiveness, and contractual obligations. I'd like to confirm if there are any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window.
[R8.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation, I'd like to summarize the key points discussed. We've considered two release strategies: a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. Our current paid media budget is $14.0M, with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift date of Sep 20, 2026. We've identified contractual constraints, including an exhibitor window covenant and a merchandising tie-in license. To confirm, are there any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window, and how might it impact our marketing effectiveness and contractual obligations?
[R8.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation, I'd like to confirm that we've considered the key contractual constraints, including the exhibitor window covenant and merchandising tie-in license. We should also be aware of our international dubbing and ADR requirements. Let's discuss any internal triggers or thresholds that might be affected by shortening the theatrical window to 18 days.

[R9.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation, let's summarize the key points discussed. We've considered two release strategies: a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. We've identified contractual constraints, including an exhibitor window covenant and a merchandising tie-in license. We need to assess the impact of shortening the window on our distribution economics, marketing effectiveness, and contractual obligations. I'd like to confirm if there are any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window.
[R9.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation, I'd like to summarize the key points discussed. We've considered two release strategies: a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. Our current paid media budget is $14.0M, with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift date of Sep 20, 2026. We've identified contractual constraints, including an exhibitor window covenant and a merchandising tie-in license. To confirm, are there any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window, and how might it impact our marketing effectiveness and contractual obligations?
[R9.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation, I'd like to confirm that we've considered the key contractual constraints, including the exhibitor window covenant and merchandising tie-in license. We should also be aware of our international dubbing and ADR requirements. Let's discuss any internal triggers or thresholds that might be affected by shortening the theatrical window to 18 days.

[R10.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation, let's summarize the key points discussed. We've considered two release strategies: a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. We've identified contractual constraints, including an exhibitor window covenant and a merchandising tie-in license. We need to assess the impact of shortening the window on our distribution economics, marketing effectiveness, and contractual obligations. I'd like to confirm if there are any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window.
[R10.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation, I'd like to summarize the key points discussed. We've considered two release strategies: a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. Our current paid media budget is $14.0M, with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift date of Sep 20, 2026. We've identified contractual constraints, including an exhibitor window covenant and a merchandising tie-in license. To confirm, are there any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window, and how might it impact our marketing effectiveness and contractual obligations?
[R10.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation, I've considered the key contractual constraints, including the exhibitor window covenant and merchandising tie-in license. We've also discussed our international dubbing and ADR requirements. I believe we've covered the main contractual aspects. Let's summarize our findings and assess the impact of shortening the theatrical window on our distribution economics, marketing effectiveness, and contractual obligations.

[R11.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation, let's summarize the key points discussed. We've considered two release strategies: a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. We've identified contractual constraints, including an exhibitor window covenant and a merchandising tie-in license. We need to assess the impact of shortening the window on our distribution economics, marketing effectiveness, and contractual obligations. I'd like to confirm if there are any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window.
[R11.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation, I'd like to summarize the key points discussed. We've considered two release strategies: a 45-day exclusive theatrical window and an alternate scenario with PVOD availability on day 18. Our current paid media budget is $14.0M, with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift date of Sep 20, 2026. We've identified contractual constraints, including an exhibitor window covenant and a merchandising tie-in license. To confirm, are there any internal triggers or thresholds that we need to be aware of regarding the shortened theatrical window, and how might it impact our marketing effectiveness and contractual obligations?
[R11.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation, I've considered the key contractual constraints, including the exhibitor window covenant and merchandising tie-in license. We've also discussed our international dubbing and ADR requirements. I believe we've covered the main contractual aspects. Let's summarize our findings and assess the impact of shortening the theatrical window on our distribution economics, marketing effectiveness, and contractual obligations.

[R12.1] Theatrical & Windowing Strategy Director (leave, public): 
[R12.2] Marketing Analytics & Media Planning Lead (leave, public): 
[R12.3] Legal & Business Affairs Counsel (leave, public): 

[R13.1] Theatrical & Windowing Strategy Director (leave, public): 
[R13.2] Marketing Analytics & Media Planning Lead (leave, public): 
[R13.3] Legal & Business Affairs Counsel (leave, public): 

[R14.1] Theatrical & Windowing Strategy Director (leave, public): 
[R14.2] Marketing Analytics & Media Planning Lead (leave, public): 
[R14.3] Legal & Business Affairs Counsel (leave, public): 

[R15.1] Theatrical & Windowing Strategy Director (leave, public): 
[R15.2] Marketing Analytics & Media Planning Lead (leave, public): 
[R15.3] Legal & Business Affairs Counsel (leave, public): 

[R16.1] Theatrical & Windowing Strategy Director (leave, public): 
[R16.2] Marketing Analytics & Media Planning Lead (leave, public): 
[R16.3] Legal & Business Affairs Counsel (leave, public): 

[R17.1] Theatrical & Windowing Strategy Director (leave, public): 
[R17.2] Marketing Analytics & Media Planning Lead (leave, public): 
[R17.3] Legal & Business Affairs Counsel (leave, public): 

[R18.1] Theatrical & Windowing Strategy Director (leave, public): 
[R18.2] Marketing Analytics & Media Planning Lead (leave, public): 
[R18.3] Legal & Business Affairs Counsel (leave, public): 

[R19.1] Theatrical & Windowing Strategy Director (leave, public): 
[R19.2] Marketing Analytics & Media Planning Lead (leave, public): 
[R19.3] Legal & Business Affairs Counsel (leave, public): 

